The 1 AI Stock I’d Put in a Time Capsule and Open in 2036
Absci stands at the forefront of an emerging AI-biotech revolution, aiming to reinvent how new drugs are discovered. Though the investment case is undeniably speculative, many believe it could redefine pharmaceutical innovation by 2036.
18 hours ago
2 mins read